Issues related to genetic testing are also presented in the section on FAP. (See Clinical manifestations and diagnosis of familial adenomatous polyposis and Familial adenomatous polyposis: Screening and management of patients and families.)
Side Effects. All medicines can have side effects. Sometimes they are serious, but most of the time they are not. RISPA is generally well-tolerated and side effects are often hard to distinguish from the disease symptoms. You may need medical treatment if you get some of the side effects.Tell your doctor as soon as possible if you do not feel well while you are using this medicine.he usual starting dose of RISPA is 1 mg twice a day. This will be gradually increased by your doctor to suit your needs. From then on, the dose can be taken once a day or twice a day according to your doctor's instructions. For long-term treatment, your doctor will determine the dose most suitable for you.
March 1, 2011 -- The FDA has approved a new treatment for people with worsening symptoms of severe chronic obstructive pulmonary disease (COPD), a lung disorder that makes breathing difficult. The drug, roflumilast -- carrying the trade name Daliresp -- will be sold in pill form, unlike some other medications for COPD, which are inhaled. The FDA says roflumilast, a new drug class for COPD treatment, is an inhibitor of an enzyme called phosphodiesterase type 4 (PDE-4). The pill is recommended for people with severe COPD associated with chronic bronchitis who have had flares. Roflumilast has been shown to reduce the risk of COPD flares in this group.